Literature DB >> 20496032

Oxidative modifications in glycated insulin.

Sofia Guedes1, Rui Vitorino, Maria R M Domingues, Francisco Amado, Pedro Domingues.   

Abstract

At the present, the term "glycoxidation" is recognized as the synergistic interaction between glycation and oxidative processes which, with the help of redox-active metals, consequently leads to the production of deleterious tissue modifications. The association between glycation and oxidation events is considered one of the major factors in the accumulation of non-functional damaged proteins, enhancing the oxidative damage at the cellular level. Because of the central role of insulin in the biology of diabetes, we investigated the site-specific oxidation of native and glycated insulin (mono, di, and tri-glycated forms), through metal-catalyzed oxidation, with a combination of liquid chromatography and mass spectrometry. With this approach we were able to identify the residues that were mainly oxidized, and peptide sequences resulting from oxidative cleavage of insulin. Tyrosine, phenylalanine, and cysteine were the main affected residues. Time-course analysis (0-48 h) of the oxidative damage enabled to detect more pronounced and earlier oxidative modifications in the case of glycated insulin. We also observed more severe oxidative damage as the number of glycation sites increased in insulin. These oxidative modifications included other oxidized residues, namely proline, histidine, valine, leucine, and glycine, which were shown to be carbonylated. In addition, we identified new sites of peptide cleavage with the formation of new fragments, derived mainly from chain B, which were both glycated and oxidatively modified. Peptide fragmentation occurred mainly between the residues phenylalanine, glycine, leucine, and tyrosine. Moreover, for diglycated and triglycated forms we observed further oxidative cleavage occurring in both chains, with oxidation and fragmentation of residues occurring near cysteine bridges, especially in chain A.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20496032     DOI: 10.1007/s00216-010-3757-x

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  6 in total

Review 1.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

3.  Antibodies to post-translationally modified insulin in type 1 diabetes.

Authors:  Rocky Strollo; Chiara Vinci; Mayda H Arshad; David Perrett; Claudio Tiberti; Francesco Chiarelli; Nicola Napoli; Paolo Pozzilli; Ahuva Nissim
Journal:  Diabetologia       Date:  2015-09-08       Impact factor: 10.122

4.  Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.

Authors:  Rocky Strollo; Chiara Vinci; Y K Stella Man; Sara Bruzzaniti; Erica Piemonte; Ghadeer Alhamar; Silvia Irina Briganti; Ilaria Malandrucco; Flavia Tramontana; Chiara Fanali; James Garnett; Roberto Buccafusca; Perrin Guyer; Mark Mamula; Eddie A James; Paolo Pozzilli; Johnny Ludvigsson; Paul G Winyard; Mario Galgani; Ahuva Nissim
Journal:  Diabetologia       Date:  2022-10-07       Impact factor: 10.460

5.  Behavior of Regular Insulin in a Parenteral Nutrition Admixture: Validation of an LC/MS-MS Assay and the In Vitro Evaluation of Insulin Glycation.

Authors:  Heloise Henry; Jean-François Goossens; Mostafa Kouach; Damien Lannoy; David Seguy; Thierry Dine; Pascal Odou; Catherine Foulon
Journal:  Pharmaceutics       Date:  2022-05-18       Impact factor: 6.525

6.  Chemical modifications in aggregates of recombinant human insulin induced by metal-catalyzed oxidation: covalent cross-linking via michael addition to tyrosine oxidation products.

Authors:  Riccardo Torosantucci; Olivier Mozziconacci; Victor Sharov; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2012-05-10       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.